Paclitaxel poliglumex (PPX), cisplatin and concurrent radiation for esophageal and gastric cancer: A phase I study

被引:0
|
作者
Dipetrillo, T.
Evans, D.
Akerman, P.
Miner, T.
Millis, R.
Jean, M.
Henderson, D.
Oldham, F.
Eisenfeld, A.
Safran, H.
机构
[1] Brown Univ, Oncol Grp, Providence, RI 02912 USA
[2] Cell Therapeut Inc, Seattle, WA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
15130
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Paclitaxel poliglumex (PPX-xyotax) and concurrent radiation for esophageal and gastric cancer - A phase I study
    Dipetrillo, Tom
    Milas, Luka
    Evans, Devon
    Akerman, Paul
    Ng, Thomas
    Miner, Tom
    Cruff, Dennis
    Chauhan, Bharti
    Iannitti, David
    Harrington, David
    Safran, Howard
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (04): : 376 - 379
  • [2] Neoadjuvant paclitaxel poliglumex (PPX), cisplatin, and radiation (RT) for esophageal cancer
    Ng, T.
    Fontaine, J.
    Suntharalingam, M.
    Dipetrillo, T.
    Horiba, M. N.
    Oldenburg, N. B.
    Perez, K.
    Chen, W.
    Habr, F.
    Safran, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Paclitaxel poliglumex (PPX) and concurrent radiation for treatment of patients with esophageal or gastric cancer: A dose-ranging study.
    Dipetrillo, TA
    Chauhan, B
    Akerman, P
    Ng, T
    Miner, T
    Cruff, D
    Rich, T
    Oldham, FB
    Countouriotis, A
    Safran, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 324S - 324S
  • [4] A phase I study of paclitaxel poliglumex (PPX) in combination with cisplatin (CIS) for patients (pts) with advanced cancer.
    Skubitz, KM
    Verschraegen, CF
    Daud, A
    Bernareggi, A
    Oldham, FB
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 157S - 157S
  • [5] Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: A phase II trial
    Ng, T.
    DiPetrillo, T.
    Suntharalingam, M.
    Fontaine, J.
    McNulty, B.
    Akerman, P.
    Chen, W.
    Horiba, M. N.
    Burrows, W.
    Safran, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Neoadjuvant Paclitaxel Poliglumex, Cisplatin, and Radiation for Esophageal Cancer A Phase 2 Trial
    Dipetrillo, Thomas
    Suntharalingam, Mohan
    Ng, Thomas
    Fontaine, Jacques
    Horiba, Naomi
    Oldenburg, Nicklas
    Perez, Kimberly
    Birnbaum, Ari
    Battafarano, Richard
    Burrows, Whitney
    Safran, Howard
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (01): : 64 - 67
  • [7] Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer
    Safran, H
    Gaissert, H
    Akerman, P
    Hesketh, PJ
    Chen, MH
    Moore, T
    Koness, J
    Graziano, S
    Wanebo, HJ
    CANCER INVESTIGATION, 2001, 19 (01) : 1 - 7
  • [8] Phase I evaluation of paclitaxel poliglumex (PPX) administered weekly for patients with advanced cancer.
    Takimoto, CH
    Schwartz, G
    Romero, O
    Patnaik, A
    Tolcher, A
    Garrison, M
    Oldham, FB
    Bernareggi, A
    Rowinsky, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 145S - 145S
  • [9] Phase I evaluation of paclitaxel poliglumex (PPX) administered weekly for patients with advanced cancer.
    Takimoto, CH
    Verschraegen, C
    Young, D
    Oldham, FB
    Bernareggi, A
    Rowinsky, EK
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9118S - 9118S
  • [10] Phase I study of neoadjuvant paclitaxel and concurrent radiation for locally advanced gastric cancer
    Safran, H
    Wanebo, HJ
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 1331 - 1334